|
PRDM4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.292800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.764200E-01 |
| Normal-vs-Stage2 |
3.444400E-01 |
| Normal-vs-Stage3 |
6.531400E-01 |
| Normal-vs-Stage4 |
7.216600E-01 |
| Stage1-vs-Stage2 |
6.605000E-01 |
| Stage1-vs-Stage3 |
9.131200E-01 |
| Stage1-vs-Stage4 |
9.960200E-01 |
| Stage2-vs-Stage3 |
6.598800E-01 |
| Stage2-vs-Stage4 |
7.750000E-01 |
| Stage3-vs-Stage4 |
9.540200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.027200E-01 |
| Normal-vs-AfricanAmerican |
8.417000E-01 |
| Normal-vs-Asian |
2.250000E-01 |
| Caucasian-vs-AfricanAmerican |
7.262800E-01 |
| Caucasian-vs-Asian |
5.485400E-01 |
| AfricanAmerican-vs-Asian |
4.587800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.758600E-01 |
| Normal-vs-Female |
2.621800E-01 |
| Male-vs-Female |
4.931600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.587760E-01 |
| Normal-vs-Extreme_Weight |
2.073200E-01 |
| Normal-vs-Obese |
8.492600E-01 |
| Normal-vs-Extreme_Obese |
5.740200E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.954000E-01 |
| Normal_Weight-vs-Obese |
3.131000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.858000E-01 |
| Extreme_Weight-vs-Obese |
3.700400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.314800E-01 |
| Obese-vs-Extreme_Obese |
2.606400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.705000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.149800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.254600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.657200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.519800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.378200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.828000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.142200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.110400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.970000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.419200E-01 |
| Normal-VS-Type2 PRCC |
3.017200E-01 |
| Normal-VS-KIRP CIMP |
9.077700E-02 |
| Normal-VS-Unclassified PRCC |
9.734000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.710400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.217200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.682400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.747400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.708400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.208800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.750270E-02 |
| Normal-vs-N1 |
2.678200E-01 |
| Normal-vs-N2 |
8.01490000000848E-05 |
| N0-vs-N1 |
6.040700E-03 |
| N0-vs-N2 |
3.114600E-01 |
| N1-vs-N2 |
2.681000E-03 |
|
|
